Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease

BACKGROUND/PURPOSE: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease ranging in severity from steatosis to cirrhosis. Type 2 diabetes mellitus is a cause of primary NAFLD. Thiazolidinediones have been shown to enhance insulin sensitivity, improve glycemic control in type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chao-Hung, Leung, Ching-Hsiang, Liu, Sung-Chen, Chung, Cheng-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association & Elsevier. Published by Elsevier (Singapore) Pte Ltd 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134933/
https://www.ncbi.nlm.nih.gov/pubmed/16959622
http://dx.doi.org/10.1016/S0929-6646(09)60202-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134933/
https://www.ncbi.nlm.nih.gov/pubmed/16959622
http://dx.doi.org/10.1016/S0929-6646(09)60202-3

Ejemplares similares